K. Raghavendra Rao
K. Raghavendra Rao publishes mostly in Organic Chemistry, Molecular Biology and Biotechnology, on topics such as Synthesis and Biological Evaluation, Quinazolinone synthesis and applications and Multicomponent Synthesis of Heterocycles.
- World rank
- #6,918,734 of 7,710,434 ranked researchers
- Rank in India
- #237,416 of 280,097
- Works
- 17
- Citations
- 169
- Citations per work
- 9.9
What does K. Raghavendra Rao research?
K. Raghavendra Rao's work is mostly in Chemistry (68%), Biochemistry, Genetics and Molecular Biology (26%), Pharmacology, Toxicology and Pharmaceutics (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1268.0%
- Chemistry1268.0%
- Life Sciences528.0%
- Everything else14.0%
- 1Organic Chemistry68% of their works
- 2Molecular Biology18% of their works
- 3Biotechnology4% of their works
- 4Biochemistry2% of their works
- 5Cancer Research2% of their works
- 6Pharmacology2% of their works
Research topics
- Synthesis and Biological Evaluation
- Quinazolinone synthesis and applications
- Multicomponent Synthesis of Heterocycles
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthetic Organic Chemistry Methods
- Marine Sponges and Natural Products
- Synthesis and bioactivity of alkaloids
- Chemical synthesis and alkaloids
Which keywords describe K. Raghavendra Rao's research?
The keywords of their largest research topics: Synthesis, Biological Evaluation, Anticancer, Anticancer Agents, Antimicrobial, Alkaloids, Antimicrobial Activity and Quinoxaline.
- Sponge-Associated Microorganisms
- Marine Natural Products
- Beta-Carboline Alkaloids
- Ruthenium Catalysts
- Phenothiazines
- Multicomponent Reactions
- Quinazoline
- Quinoxaline
- Alkaloids
- Anticancer Agents
- Biological Evaluation
- Synthesis
- Anticancer
- Antimicrobial
- Antimicrobial Activity
- Indirubin
- Green Chemistry
- Biological Activities
- Olefin Metathesis
- Amaryllidaceae
- Galanthamine
- Pharmacological Functions
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Synthesis225 topics
- Biological Evaluation142 topics
- Anticancer123 topics
- Anticancer Agents102 topics
- Antimicrobial102 topics
- Alkaloids82 topics
- Antimicrobial Activity81 topic
- Quinoxaline81 topic
- Indirubin61 topic
- Quinazoline61 topic
- Green Chemistry51 topic
- Multicomponent Reactions51 topic
- Biological Activities41 topic
- Phenothiazines41 topic
- Olefin Metathesis31 topic
- Ruthenium Catalysts31 topic
- Amaryllidaceae21 topic
- Beta-Carboline Alkaloids21 topic
- Galanthamine21 topic
- Marine Natural Products21 topic
- Pharmacological Functions21 topic
- Sponge-Associated Microorganisms21 topic
Where does K. Raghavendra Rao work?
K. Raghavendra Rao's main affiliation in the publication record is Dr. Reddy's Laboratories (India), India.
How many publications and citations does K. Raghavendra Rao have?
OpenAlex counts 17 works and 169 citations for K. Raghavendra Rao, an h-index of 7, ranking #6,918,734 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about K. Raghavendra Rao. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.